share_log

Procter & Gamble | 4: Statement of changes in beneficial ownership of securities-Director LUNDGREN TERRY J

Procter & Gamble | 4: Statement of changes in beneficial ownership of securities-Director LUNDGREN TERRY J

寶潔 | 4：持股變動聲明-董事 LUNDGREN TERRY J
美股SEC公告 ·  2024/12/12 04:00

Moomoo AI 已提取核心訊息

On 12/10/2024, Terry J. Lundgren, an executive of Procter & Gamble, acquired 211 shares of common stock at $0 per share through a grant or award. This transaction increased Lundgren's direct ownership to 41,969.8318 shares.In addition to the directly held shares, Lundgren indirectly owns 530 shares through shares held by spouse. The total transaction value was not disclosed due to the $0 price per share for the granted stocks.This stock acquisition appears to be part of an executive compensation package, likely tied to performance or retention incentives. The transaction has been completed, potentially reflecting the company's strategy for aligning executive interests with shareholder value.
On 12/10/2024, Terry J. Lundgren, an executive of Procter & Gamble, acquired 211 shares of common stock at $0 per share through a grant or award. This transaction increased Lundgren's direct ownership to 41,969.8318 shares.In addition to the directly held shares, Lundgren indirectly owns 530 shares through shares held by spouse. The total transaction value was not disclosed due to the $0 price per share for the granted stocks.This stock acquisition appears to be part of an executive compensation package, likely tied to performance or retention incentives. The transaction has been completed, potentially reflecting the company's strategy for aligning executive interests with shareholder value.
在2024年12月10日，寶潔的高管特里·J·倫德格倫以每股0美元的價格通過授予或獎勵獲得了211股普通股。這筆交易使倫德格倫的直接持股增至41,969.8318股。除了直接持有的股票，倫德格倫還通過配偶持有的股票間接擁有530股。由於授予股票的每股價格爲0美元，因此未披露總交易價值。這次股票收購似乎是高管薪酬方案的一部分，可能與績效或保留激勵相關。該交易已完成，可能反映了公司將高管利益與股東價值對齊的策略。
在2024年12月10日，寶潔的高管特里·J·倫德格倫以每股0美元的價格通過授予或獎勵獲得了211股普通股。這筆交易使倫德格倫的直接持股增至41,969.8318股。除了直接持有的股票，倫德格倫還通過配偶持有的股票間接擁有530股。由於授予股票的每股價格爲0美元，因此未披露總交易價值。這次股票收購似乎是高管薪酬方案的一部分，可能與績效或保留激勵相關。該交易已完成，可能反映了公司將高管利益與股東價值對齊的策略。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    樸荷生物科技
    PHH
    -- 12.790
    雷特控股
    RAY
    -- 2.040
    大樹雲
    DSY
    -- 1.100
    聯合利華(英國)
    UL
    -- 59.180
    Kenvue
    KVUE
    -- 23.700
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    中概股財報季火熱：驚喜盈利能否延續漲勢？
    1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？ 展开
    中國兩會：會議前後股票價格變動的關鍵要點